Nervgen Pharma NGEN
NASDAQ NGEN
$1.52 -0.02 (-1.30%)
As of: Oct 21, 2026 · 1:12 PM EDT

Nervgen Pharma (NGEN) Retained Earnings (2024 - 2026)

Updated

Nervgen Pharma (NGEN) recorded Retained Earnings of -$128.43 million in the quarter ended Jun 30, 2026.

Analysis

Nervgen Pharma (NGEN) Retained Earnings (2024 - 2026) Analysis & Trends

As of Dec 31, 2025, Nervgen Pharma reported Retained Earnings of -$105.04 million.

  • Across earlier years, Retained Earnings came in at -$74.97 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Eli Lilly 1,134.50 Bn 1,103.09 Bn 19.71 Bn 31.89 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn 171.67 Bn
3 AbbVie 500.82 Bn 473.93 Bn 12.70 Bn -17.33 Bn
4 Merck 367.31 Bn 321.69 Bn 12.21 Bn 63.27 Bn
5 Novartis Ag 297.77 Bn 261.76 Bn 11.24 Bn -
6 Astrazeneca 261.35 Bn 235.04 Bn 12.86 Bn 12.59 Bn
7 Amgen 235.40 Bn 190.80 Bn 7.24 Bn -22.28 Bn
8 Gilead Sciences 190.59 Bn 164.79 Bn 6.22 Bn 2.20 Bn
9 Pfizer 169.39 Bn 116.04 Bn 10.94 Bn 112.09 Bn
10 Nervgen Pharma 109.94 Mn 8.82 Mn - -125.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -125.03 Mn
Mar 31, 2026 -106.57 Mn
Dec 31, 2025 -107.17 Mn
Dec 31, 2024 -71.53 Mn
API Access

Nervgen Pharma Retained Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=retained-earnings&ticker=NGEN&period=max&api_key=YOUR_API_KEY